Drug news
Incivo will launch in Germany first for Hepatitis C
Virco-Virology, a Janssen Pharmaceutical subsidiary, will launch Incivo (telaprevir), the treatment for hepatitis C virus in Germany within a next week or so The European Commission gave approval on 20 September 2011.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.